VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 97 filers reported holding VERONA PHARMA PLC in Q1 2023. The put-call ratio across all filers is 1.24 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $105 | – | 5,235 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 901,943 | $3,716,000 | 2.47% |
venBio Partners LLC | 456,770 | $1,882,000 | 1.60% |
Aisling Capital Management LP | 443,596 | $1,828,000 | 0.80% |
Vivo Capital, LLC | 1,492,951 | $6,151,000 | 0.56% |
NEA Management Company, LLC | 1,219,674 | $5,025,000 | 0.26% |
Novo Holdings A/S | 740,740 | $3,052,000 | 0.20% |
Orbimed Advisors | 1,250,396 | $5,152,000 | 0.09% |
Clear Creek Financial Management, LLC | 37,500 | $170,000 | 0.06% |
Tekla Capital Management LLC | 253,179 | $1,043,000 | 0.05% |
WEDBUSH SECURITIES INC | 70,950 | $292,000 | 0.04% |